5 Best Biotech Stocks to Invest In

4. Iovance Biotherapeutics, Inc. (IOVA)

The small-cap clinical-stage biotechnology company Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is also among the long-running investments of billionaire biotech hedge fund manager Joseph Edelman. IOVA is the fourth largest stock holding of the Perceptive Advisors portfolio, accounting for 4.78% of the overall portfolio.

The hedge fund manager has slashed its stake in Iovance Biotherapeutics by 14% in the latest quarter to capitalize on share price gains. Share of Iovance soared 65% in 2020, extending the five years gains to 500%. Iovance Biotherapeutics focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient’s immune system to eradicate cancer cells.

Follow Iovance Biotherapeutics Inc. (NASDAQ:IOVA)